<DOC>
	<DOCNO>NCT00823953</DOCNO>
	<brief_summary>Diabetes common disease treat traditional medicine century modern medicine become available . A common remedy Diabetes Mellitus different culture momordica charantia ( karela Bitter gourd ) . The use alternative medicine common among Pakistani population . This study plan find effect administer freeze dry powder momordica charantia three week glycemic profile insulin resistance treatment naiive patient mild Type 2 diabetes .</brief_summary>
	<brief_title>Glycemic Response Momordica Charantia Type 2 Diabetes</brief_title>
	<detailed_description>Momordica charantia commonly consume vegetable , formed part subcontinental diet since century . It traditionally use treat diabetes across three continent , glycemic effect investigate unblinded trial , far properly design double blind investigation action insulin resistance carry . In study , randomise placebo control double-blind trial carry mild type 2 diabetic patient , study effect escalate dos Momordica charantia administer form capsule trial phase three week , glycemic control parameter insulin resistance type 2 diabetes . Among parameter test glucose index lipid profile insulin level . The effect Momordica charantia administration insulin resistance assess use HOMA-IR model and/ hyperinsulinemic , euglycemic clamp . The selection patient mild hyperglycemia do offset glucose spill-off effect occur beyond real threshold , make glucose tolerance curve non-linear beyond level .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>1 . Adult Type 2 diabetic mild degree hyperglycemia ( FBG &gt; 126 &lt; 200 mg/dl ) 2 . Absence serious comorbid condition 3 . Patients agree participate trial 1 . Type 1 diabetic 2 . Pregnancy 3 . Paediatric age group 4 . Patients know allergic Momordica charantia 5 . Serious cardiorespiratory illness , previous myocardial infarction , angina pectoris , heart failure , uncontrolled hypertension â‰¥ stage 2 , COPD , asthma , active pulmonary tuberculosis 6 . Significant hepatic impairment : ALT &gt; 60 , Bilirubin &gt; 2 mg/dl 7 . Significant renal impairment : S/creatinine &gt; 1.5 mg/dl , albuminuria &gt; 1+ 8 . Patients condition likely interfere absorption trial therapy : malabsorption , chronic diarrhoea , intestinal resection , blind loop syndrome 9 . Patients withhold consent 10 . Patients , male female , desire pregnancy trial phase . 11 . Secondary cause diabetes 12 . Patients use drug influence glucose metabolism : steroid , hormonal contraception , menopausal HRT , diazoxide , phenytoin , colchicine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>diabetes type 2</keyword>
</DOC>